OBJECTIVE: Identifying treatments to improve functioning and reduce negative symptoms in consumers with schizophrenia is of high public health significance. METHOD: In this randomized clinical trial, participants with schizophrenia or schizoaffective disorder (N = 149) were randomly assigned to cognitive behavioral social skills training (CBSST) or an active goal-focused supportive contact (GFSC) control condition. CBSST combined cognitive behavior therapy with social skills training and problem-solving training to improve functioning and negative symptoms. GFSC was weekly supportive group therapy focused on setting and achieving functioning goals. Blind raters assessed functioning (primary outcome: Independent Living Skills Survey [ILSS]), CBSST skill knowledge, positive and negative symptoms, depression, and defeatist performance attitudes. RESULTS: In mixed-effects regression models in intent-to-treat analyses, CBSST skill knowledge, functioning, amotivation/asociality negative symptoms, and defeatist performance attitudes improved significantly more in CBSST relative to GFSC. In both treatment groups, comparable improvements were also found for positive symptoms and a performance-based measure of social competence. CONCLUSIONS: The results suggest CBSST is an effective treatment to improve functioning and experiential negative symptoms in consumers with schizophrenia, and both CBSST and supportive group therapy actively focused on setting and achieving functioning goals can improve social competence and reduce positive symptoms.
RCT Entities:
OBJECTIVE: Identifying treatments to improve functioning and reduce negative symptoms in consumers with schizophrenia is of high public health significance. METHOD: In this randomized clinical trial, participants with schizophrenia or schizoaffective disorder (N = 149) were randomly assigned to cognitive behavioral social skills training (CBSST) or an active goal-focused supportive contact (GFSC) control condition. CBSST combined cognitive behavior therapy with social skills training and problem-solving training to improve functioning and negative symptoms. GFSC was weekly supportive group therapy focused on setting and achieving functioning goals. Blind raters assessed functioning (primary outcome: Independent Living Skills Survey [ILSS]), CBSST skill knowledge, positive and negative symptoms, depression, and defeatist performance attitudes. RESULTS: In mixed-effects regression models in intent-to-treat analyses, CBSST skill knowledge, functioning, amotivation/asociality negative symptoms, and defeatist performance attitudes improved significantly more in CBSST relative to GFSC. In both treatment groups, comparable improvements were also found for positive symptoms and a performance-based measure of social competence. CONCLUSIONS: The results suggest CBSST is an effective treatment to improve functioning and experiential negative symptoms in consumers with schizophrenia, and both CBSST and supportive group therapy actively focused on setting and achieving functioning goals can improve social competence and reduce positive symptoms.
Authors: Samir Sabbag; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson; Philip D Harvey Journal: Schizophr Res Date: 2012-03-02 Impact factor: 4.939
Authors: William P Horan; Yuri Rassovsky; Robert S Kern; Junghee Lee; Jonathan K Wynn; Michael F Green Journal: J Psychiatr Res Date: 2009-12-14 Impact factor: 4.791
Authors: Eric Granholm; Ivan Ruiz; Yuliana Gallegos-Rodriguez; Jason Holden; Peter C Link Journal: Biol Psychiatry Date: 2015-09-15 Impact factor: 13.382
Authors: David T Turner; Edel McGlanaghy; Pim Cuijpers; Mark van der Gaag; Eirini Karyotaki; Angus MacBeth Journal: Schizophr Bull Date: 2018-04-06 Impact factor: 9.306
Authors: L Felice Reddy; William P Horan; Deanna M Barch; Robert W Buchanan; James M Gold; Stephen R Marder; Jonathan K Wynn; Jared Young; Michael F Green Journal: Schizophr Bull Date: 2018-10-17 Impact factor: 9.306
Authors: Daniel Fulford; Jasmine Mote; David E Gard; Kim T Mueser; Kathryn Gill; Lawrence Leung; Kara Dillaway Journal: J Behav Cogn Ther Date: 2020-07-17
Authors: Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548